arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

DocGo Inc.

DCGO
$0.36 0.00 (+0.67%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
6 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

DocGo Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $35.7M
Dividend Yield —
Revenue Growth -47.7% ↘
Op. Margin -55.3% ↘
ROIC -129.3% ↘
FCF / Share $0.30 ↘
Trailing P/E —
Price / Book 0.3x
FCF Yield 83.9%
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Sep 23, 2026.

6-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$322.20M
↓ -47.7% —
Net Income Profit after all expenses
$-182.40M
↓ -1465.2% —
Operating Margin Operating profit as % of sales
-55.3%
↓ -1287.5% 5th
FCF / Share Free cash flow per share
$0.30
↓ -53.5% —
Long-Term Debt Long-term obligations
$235.58K
↑ +1228.7% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
23
Returns
6
Financial Health ↓
54
Cash Quality ↑
17

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 24 quarters